GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » 3-Year Revenue Growth Rate

Chandra Bhagat Pharma (BOM:542934) 3-Year Revenue Growth Rate : 46.30% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma 3-Year Revenue Growth Rate?

Chandra Bhagat Pharma's Revenue per Share for the six months ended in Sep. 2024 was ₹86.26.

During the past 12 months, Chandra Bhagat Pharma's average Revenue per Share Growth Rate was -13.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 46.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Chandra Bhagat Pharma was 46.30% per year. The lowest was -10.00% per year. And the median was -1.20% per year.


Competitive Comparison of Chandra Bhagat Pharma's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chandra Bhagat Pharma's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Chandra Bhagat Pharma's 3-Year Revenue Growth Rate falls into.


;
;

Chandra Bhagat Pharma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Chandra Bhagat Pharma  (BOM:542934) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Chandra Bhagat Pharma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Chandra Bhagat Pharma Business Description

Traded in Other Exchanges
N/A
Address
Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma Headlines

No Headlines